| |
ME/CFS (n = 32)
|
Controls (n = 11)
|
|---|
|
Age (years)
|
42 ± 7
|
46 ± 5
|
|
Sex ratio (F/M)
|
24/12
|
6/5
|
|
ME/CFS duration (y)
|
5 ± 1
| |
|
At rest
|
|
RAA/TBARS
|
91 ± 19*
|
129 ± 15
|
|
CD26-expression (AU)
|
2.72 + 0.09*
|
3.60 ± 0.09
|
|
End exercise
| | |
|
VO2max (ml min−1 kg−1)
|
23 ± 1
|
26 ± 4
|
|
Δ M-wave (%)
|
−41 ± 8**
|
+8 ± 6
|
|
ΔTBARS (%)
|
+50 ± 10**
|
+15 ± 7
|
- At rest: RAA/TBARS: ratio of antioxidant response (Reduced ascorbic acid, RAA) to lipid peroxidation (Thiobarbituric acid reactive substances, TBARS); CD26-expression measured via DPP-IV activity (AU: arbitrary unit)
- Exercise: VO2 max (maximal oxygen uptake); ΔM-wave amplitude: (maximal decrease in M-wave amplitude evoked in the rectus femoris); ΔTBARS (maximal increase in TBARS post-exercise) (Mean + SEM; * p < 0.05; ** p < 0.01)
